Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 7010-7021

  Peltier, Daniel C ^a   Simms, Allison ^a   Farmer, Jocelyn R ^a   Miller, David J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 13; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; NERVE CELL; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SENDAI VIRUS; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CELL LINE; CYTOPLASM; DNA MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNITY, INNATE; IMMUNOBLOTTING; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 77953627102     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904133     Document Type: Article

References (80)

1. Kumar, H., T. Kawai, and S. Akira. 2009. Pathogen recognition in the innate immune response. Biochem. J. 420: 1-16.
2. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27: 370-383.
3. Schmidt, A., T. Schwerd, W. Hamm, J. C. Hellmuth, S. Cui, M. Wenzel, F. S. Hoffmann, M. C. Michallet, R. Besch, K. P. Hopfner, et al. 2009. 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. USA 106: 12067-12072.
4. Schlee, M., A. Roth, V. Hornung, C. A. Hagmann, V. Wimmenauer, W. Barchet, C. Coch, M. Janke, A. Mihailovic, G. Wardle, et al. 2009. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25-34.
5. Pichlmair, A., O. Schulz, C. P. Tan, J. Rehwinkel, H. Kato, O. Takeuchi, S. Akira, M. Way, G. Schiavo, and C. Reis e Sousa. 2009. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83: 10761-10769.
6. Yoneyama, M., and T. Fujita. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227: 54-65.
7. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47.
8. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
9. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28. (Pubitemid 41019654)
10. Kalali, B. N., G. Köllisch, J. Mages, T. Müller, S. Bauer, H. Wagner, J. Ring, R. Lang, M. Mempel, and M. Ollert. 2008. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J. Immunol. 181: 2694-2704.
11. Wang, Q., D. R. Nagarkar, E. R. Bowman, D. Schneider, B. Gosangi, J. Lei, Y. Zhao, C. L. McHenry, R. V. Burgens, D. J. Miller, et al. 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183: 6989-6997.
12. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
13. Barchet, W., M. Cella, B. Odermatt, C. Asselin-Paturel, M. Colonna, and U. Kalinke. 2002. Virus-induced interferon α production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 195: 507-516.
14. Sato, M., N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi, and N. Tanaka. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441: 106-110. (Pubitemid 29012382)
15. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-a/b gene induction. Immunity 13: 539-548.
16. Marié, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17: 6660-6669.
17. Zurney, J., K. E. Howard, and B. Sherry. 2007. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J. Virol. 81: 13668-13680. (Pubitemid 350247860)
18. Li, K., Z. Chen, N. Kato, M. Gale, Jr., and S. M. Lemon. 2005. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J. Biol. Chem. 280: 16739-16747.
19. Daffis, S., M. A. Samuel, B. C. Keller, M. Gale, Jr., and M. S. Diamond. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 3: e106.
20. Daffis, S., M. A. Samuel, M. S. Suthar, B. C. Keller, M. Gale, Jr., and M. S. Diamond. 2008. Interferon regulatory factor IRF-7 induces the antiviral a interferon response and protects against lethal West Nile virus infection. J. Virol. 82: 8465-8475.
21. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529. (Pubitemid 38314424)
22. Werling, D., O. C. Jann, V. Offord, E. J. Glass, and T. J. Coffey. 2009. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 30: 124-130.
23. Heinz, S., V. Haehnel, M. Karaghiosoff, L. Schwarzfischer, M. Müller, S. W. Krause, and M. Rehli. 2003. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J. Biol. Chem. 278: 21502-21509.
24. Rehli, M. 2002. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23: 375-378. (Pubitemid 34804626)
25. Griffin, D. E. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3: 493-502.
26. Jackson, A. C., J. P. Rossiter, and M. Lafon. 2006. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J. Neurovirol. 12: 229-234.
27. Préhaud, C., F. Mégret, M. Lafage, and M. Lafon. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of β interferon. J. Virol. 79: 12893-12904. (Pubitemid 41433208)
28. Cameron, J. S., L. Alexopoulou, J. A. Sloane, A. B. DiBernardo, Y. Ma, B. Kosaras, R. Flavell, S. M. Strittmatter, J. Volpe, R. Sidman, and T. Vartanian. 2007. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 27: 13033-13041.
29. Ménager, P., P. Roux, F. Mégret, J. P. Bourgeois, A. M. Le Sourd, A. Danckaert, M. Lafage, C. Préhaud, and M. Lafon. 2009. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 5: e1000315.
30. Zhou, Y., L. Ye, Q. Wan, L. Zhou, X. Wang, J. Li, S. Hu, D. Zhou, and W. Ho. 2009. Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells. J. Neurosci. Res. 87: 2916-2925.
31. Daffis, S., M. A. Samuel, M. S. Suthar, M. Gale, Jr., and M. S. Diamond. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82: 10349-10358.
32. Lathia, J. D., E. Okun, S. C. Tang, K. Griffioen, A. Cheng, M. R. Mughal, G. Laryea, P. K. Selvaraj, C. ffrench-Constant, T. Magnus, et al. 2008. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci. 28: 13978-13984.
33. Delhaye, S., S. Paul, G. Blakqori, M. Minet, F. Weber, P. Staeheli, and T. Michiels. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 103: 7835-7840.
34. Rolls, A., R. Shechter, A. London, Y. Ziv, A. Ronen, R. Levy, and M. Schwartz. 2007. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9: 1081-1088.
35. Ma, Y., J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lü, B. Kosaras, R. L. Sidman, J. J. Volpe, and T. Vartanian. 2006. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175: 209-215. (Pubitemid 44631415)
36. Moisse, K., and M. J. Strong. 2006. Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762: 1083-1093.
37. Crack, P. J., and P. J. Bray. 2007. Toll-like receptors in the brain and their potential roles in neuropathology. Immunol. Cell Biol. 85: 476-480.
38. Kappes, F., J. Fahrer, M. S. Khodadoust, A. Tabbert, C. Strasser, N. Mor-Vaknin, M. Moreno-Villanueva, A. Bürkle, D. M. Markovitz, and E. Ferrando-May. 2008. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol. Cell. Biol. 28: 3245-3257.
39. Castorena, K. M., D. C. Peltier, W. Peng, and D. J. Miller. 2008. Maturation-dependent responses of human neuronal cells to western equine encephalitis virus infection and type I interferons. Virology 372: 208-220.
40. Ronnett, G. V., L. D. Hester, J. S. Nye, K. Connors, and S. H. Snyder. 1990. Human cortical neuronal cell line: establishment from a patient with unilateral megalencephaly. Science 248: 603-605.
41. Zhang, Y., and B. R. Bhavnani. 2006. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci. 7: 49.
42. Peng, W., D. C. Peltier, M. J. Larsen, P. D. Kirchhoff, S. D. Larsen, R. R. Neubig, and D. J. Miller. 2009. Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses. J. Infect. Dis. 199: 950-957.
43. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
44. Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U. Scherf, and T. P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
45. Peverali, F. A., D. Orioli, L. Tonon, P. Ciana, G. Bunone, M. Negri, and G. Della-Valle. 1996. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 12: 457-462.
46. Encinas, M., M. Iglesias, Y. Liu, H. Wang, A. Muhaisen, V. Ceña, C. Gallego, and J. X. Comella. 2000. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75: 991-1003.
47. Paladino, P., D. T. Cummings, R. S. Noyce, and K. L. Mossman. 2006. The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J. Immunol. 177: 8008-8016.
48. Tang, S. C., T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 104: 13798-13803.
49. Greene, C. M., N. G. McElvaney, S. J. O'Neill, and C. C. Taggart. 2004. Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells. Infect. Immun. 72: 3684-3687.
50. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672. (Pubitemid 36899248)
51. Yoneyama, M., M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y. M. Loo, M. Gale, Jr., S. Akira, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175: 2851-2858. (Pubitemid 41170502)
52. Clément, J. F., A. Bibeau-Poirier, S. P. Gravel, N. Grandvaux, E. Bonneil, P. Thibault, S. Meloche, and M. J. Servant. 2008. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J. Virol. 82: 3984-3996.
53. Dong, L. W., X. N. Kong, H. X. Yan, L. X. Yu, L. Chen, W. Yang, Q. Liu, D. D. Huang, M. C. Wu, and H. Y. Wang. 2008. Signal regulatory protein α negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction. Mol. Immunol. 45: 3025-3035.
54. Sarkar, S. N., K. L. Peters, C. P. Elco, S. Sakamoto, S. Pal, and G. C. Sen. 2004. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11: 1060-1067.
55. Aksoy, E., W. Vanden Berghe, S. Detienne, Z. Amraoui, K. A. Fitzgerald, G. Haegeman, M. Goldman, and F. Willems. 2005. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-κ B activation and IFN-β synthesis downstream of Toll-like receptor 3 and 4. Eur. J. Immunol. 35: 2200-2209.
56. Hazeki, K., S. Kinoshita, T. Matsumura, K. Nigorikawa, H. Kubo, and O. Hazeki. 2006. Opposite effects of wortmannin and 2-(4-morpholinyl)-8-phenyl- 1(4H)-benzopyran-4-one hydrochloride on toll-like receptor-mediated nitric oxide production: negative regulation of nuclear factor-κB by phosphoinositide 3-kinase. Mol. Pharmacol. 69: 1717-1724.
57. Sly, L. M., M. J. Hamilton, E. Kuroda, V. W. Ho, F. L. Antignano, S. L. Omeis, C. J. van Netten-Thomas, D. Wong, H. K. Brugger, O. Williams, et al. 2009. SHIP prevents lipopolysaccharide from triggering an antiviral response in mice. Blood 113: 2945-2954.
58. Zhao, Y., M. A. Rivieccio, S. Lutz, E. Scemes, and C. F. Brosnan. 2006. The TLR3 ligand polyI: C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-kappaB and PI3 kinase pathways. Glia 54: 775-785.
59. Crabbe, T., M. J. Welham, and S. G. Ward. 2007. The PI3K inhibitor arsenal: choose your weapon! Trends Biochem. Sci. 32: 450-456.
60. Vanhaesebroeck, B., K. Ali, A. Bilancio, B. Geering, and L. C. Foukas. 2005. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30: 194-204.
61. Pomel, V., J. Klicic, D. Covini, D. D. Church, J. P. Shaw, K. Roulin, F. Burgat-Charvillon, D. Valognes, M. Camps, C. Chabert, et al. 2006. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase γ. J. Med. Chem. 49: 3857-3871.
62. Jackson, S. P., S. M. Schoenwaelder, I. Goncalves, W. S. Nesbitt, C. L. Yap, C. E. Wright, V. Kenche, K. E. Anderson, S. M. Dopheide, Y. Yuan, et al. 2005. PI 3-kinase p110β: a new target for antithrombotic therapy. Nat. Med. 11: 507-514.
63. Larsen, P. H., T. H. Holm, and T. Owens. 2007. Toll-like receptors in brain development and homeostasis. Sci. STKE 2007: pe47.
64. Vercammen, E., J. Staal, and R. Beyaert. 2008. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin. Microbiol. Rev. 21: 13-25.
65. Zhang, S. Y., E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527. (Pubitemid 47417427)
66. Wang, T., T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig, and R. A. Flavell. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10: 1366-1373.
67. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105. (Pubitemid 43827959)
68. Fredericksen, B. L., B. C. Keller, J. Fornek, M. G. Katze, and M. Gale, Jr. 2008. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82: 609-616.
69. Hazeki, K., K. Nigorikawa, and O. Hazeki. 2007. Role of phosphoinositide 3-kinase in innate immunity. Biol. Pharm. Bull. 30: 1617-1623.
70. Cosker, K. E., S. Shadan, M. van Diepen, C. Morgan, M. Li, V. Allen-Baume, C. Hobbs, P. Doherty, S. Cockcroft, and B. J. Eickholt. 2008. Regulation of PI3K signalling by the phosphatidylinositol transfer protein PITPalpha during axonal extension in hippocampal neurons. J. Cell Sci. 121: 796-803.
71. Hu, J. Y., Y. Chen, and S. Schacher. 2007. Protein kinase C regulates local synthesis and secretion of a neuropeptide required for activity-dependent long-term synaptic plasticity. J. Neurosci. 27: 8927-8939.
72. Cosker, K. E., and B. J. Eickholt. 2007. Phosphoinositide 3-kinase signalling events controlling axonal morphogenesis. Biochem. Soc. Trans. 35: 207-210.
73. Kaur, S., A. Sassano, B. Dolniak, S. Joshi, B. Majchrzak-Kita, D. P. Baker, N. Hay, E. N. Fish, and L. C. Platanias. 2008. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 105: 4808-4813.
74. Kaur, S., A. Sassano, A. M. Joseph, B. Majchrzak-Kita, E. A. Eklund, A. Verma, S. M. Brachmann, E. N. Fish, and L. C. Platanias. 2008. Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J. Immunol. 181: 7316-7323.
75. Kroczynska, B., S. Kaur, E. Katsoulidis, B. Majchrzak-Kita, A. Sassano, S. C. Kozma, E. N. Fish, and L. C. Platanias. 2009. Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals. Mol. Cell. Biol. 29: 2865-2875.
76. Colina, R., M. Costa-Mattioli, R. J. Dowling, M. Jaramillo, L. H. Tai, C. J. Breitbach, Y. Martineau, O. Larsson, L. Rong, Y. V. Svitkin, et al. 2008. Translational control of the innate immune response through IRF-7. Nature 452: 323-328. (Pubitemid 351430792)
77. Cao, W., S. Manicassamy, H. Tang, S. P. Kasturi, A. Pirani, N. Murthy, and B. Pulendran. 2008. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 9: 1157-1164.
78. Ohtani, M., S. Nagai, S. Kondo, S. Mizuno, K. Nakamura, M. Tanabe, T. Takeuchi, S. Matsuda, and S. Koyasu. 2008. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112: 635-643.
79. Detje, C. N., T. Meyer, H. Schmidt, D. Kreuz, J. K. Rose, I. Bechmann, M. Prinz, and U. Kalinke. 2009. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 182: 2297-2304.
80. Prinz, M., H. Schmidt, A. Mildner, K. P. Knobeloch, U. K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and non-redundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686.